Webinar — One Vaccine, Eight Antigens — Scaling the Unscalable

A live case study on the mosaic-8b nanoparticle vaccine, a 60-mer displaying 8 distinct receptor-binding domains engineered for broad Sarbecovirus protection. Presented by Leonardo Magneschi (VP, Research & Technology Development) and Scott Baxter (Head of Downstream Process Development), this session covered the full production journey from a CEPI-funded ($32M) collaboration with Caltech, Oxford and CPI.